ZYBT — ZHENGYE BIOTECHNOLOGY HLDG L
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 6 SEC-registered investment managers reported holding ZYBT (ZHENGYE BIOTECHNOLOGY HLDG L) in their latest 13F filings, with a combined reported value of $64.40K across 50.38K shares. That is -41.0% by share count (-3.78K shares) versus the previous quarter, while reported value moved -5.6%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 1 added to existing stakes, 1 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ZHENGYE BIOTECHNOLOGY HLDG L (ZYBT) include Pacer Advisors, Inc., Invesco Ltd, MILLENNIUM MANAGEMENT LLC, ranked by reported 13F value among the 20 institutional holders on this page.
ZYBT is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 6 | 50.38K | $64.40K | -41.0% |
| Q2 2026 | 9 | 129.34K | $87.74K | -13.8% |
| Q1 2026 | 8 | 121.04K | $113.00K | -27.2% |
| Q4 2025 | 10 | 230.30K | $264.85K | +59.5% |
| Q3 2025 | 12 | 315.25K | $1.23M | -39.2% |
| Q2 2025 | 9 | 553.13K | $2.97M | +11897.3% |
| Q1 2025 | 3 | 1.34K | $7.19K | — |
Over the 7 quarters shown, institutional share counts increased 3671% in aggregate (Q1 2025 → Q3 2026); the largest single-quarter swing was Q2 2025 (+11897.3%).
Top Institutional Holders (Q3 2026) — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 27.26K | $32.71K | 0.00% | New | |
| 17.66K | $25.61K | 0.00% | New | |
| 4.20K | $5.04K | 0.00% | Reduce | |
| 1.23K | $1.00K | 0.00% | Hold | |
| 27 | $32 | 0.00% | New | |
| 7 | $8 | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 48.87K | $33.09K | 0.00% | Add | |
| 29.07K | $19.68K | 0.00% | New | |
| 29.07K | $19.68K | 0.00% | Hold | |
| 12.73K | $8.62K | 0.00% | Reduce | |
| 7.99K | $5.41K | 0.00% | Reduce | |
| 1.23K | $1.00K | 0.00% | Hold | |
| 248 | $168 | 0.00% | Reduce | |
| 134 | $93 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold |
Q1 2026 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 44.15K | $41.27K | 0.00% | Reduce | |
| 33.39K | $31.21K | 0.00% | Reduce | |
| 29.07K | $27.17K | 0.00% | Hold | |
| 8.04K | $7.51K | 0.00% | Reduce | |
| 4.91K | $4.59K | 0.00% | Add | |
| 1.23K | $1.00K | 0.00% | New | |
| 261 | $244 | 0.00% | Reduce | |
| 1 | $1 | 0.00% | Hold |
Q4 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 63.30K | $72.79K | 0.00% | Add | |
| 59.29K | $68.18K | 0.00% | Add | |
| 34.69K | $39.89K | 0.00% | Reduce | |
| 30.58K | $35.16K | 0.00% | Add | |
| 29.07K | $33.43K | 0.00% | Hold | |
| 9.12K | $10.48K | 0.00% | Add | |
| 2.21K | $2.54K | 0.00% | Reduce | |
| 1.61K | $1.85K | 0.00% | Reduce | |
| 457 | $526 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold |
Q3 2025 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 141.90K | $772.88K | 0.00% | Add | |
| 36.45K | $95.50K | 0.00% | Reduce | |
| 34.59K | $90.62K | 0.01% | New | |
| 29.07K | $76.16K | 0.00% | Hold | |
| 21.55K | $56.45K | 0.00% | New | |
| 14.60K | $38.26K | 0.00% | New | |
| 14.60K | $38.26K | 0.00% | New | |
| 11.69K | $30.61K | 0.00% | New | |
| 4.46K | $11.69K | 0.00% | Add | |
| 4.33K | $11.34K | 0.00% | Reduce | |
| 2.01K | $5.26K | 0.00% | Reduce | |
| 1 | $3 | 0.00% | New |
Q2 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 193.98K | $1.16M | 0.00% | New | |
| 154.51K | $922.44K | 0.00% | Add | |
| 132.62K | $456.26K | 0.00% | New | |
| 36.84K | $219.93K | 0.00% | New | |
| 29.07K | $173.53K | 0.00% | New | |
| 3.34K | $19.92K | 0.00% | Add | |
| 2.44K | $14.54K | 0.00% | Add | |
| 262 | $1.56K | 0.00% | New | |
| 73 | $436 | 0.00% | New |
New Positions (Q3 2026)
- JANE STREET GROUP, LLC 27.26K sh · $32.71K
- StoneX Group Inc. 17.66K sh · $25.61K
- Robinhood Markets, Inc. 27 sh · $32
Fully Exited (vs previous quarter)
- XTX Topco Ltd sold 48.87K sh · $33.09K
- GEODE CAPITAL MANAGEMENT, LLC sold 29.07K sh · $19.68K
- Geode Capital Management sold 29.07K sh · $19.68K
- WINTON GROUP Ltd sold 12.73K sh · $8.62K
- Morgan Stanley sold 248 sh · $168
- JPMorgan Chase & Co sold 134 sh · $93
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 27.26K | — | — | — | — | 193.98K | — |
| StoneX Group Inc. | 17.66K | — | — | — | — | — | — |
| UBS Group AG | 4.20K | 7.99K | 8.04K | 9.12K | 4.33K | 154.51K | 1.29K |
| ROYAL BANK OF CANADA | 1.23K | 1.23K | 1.23K | — | — | — | — |
| Robinhood Markets, Inc. | 27 | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 7 | 1 | 1 | 1 | 1 | — | — |
| Pacer Advisors, Inc. | — | — | — | — | 141.90K | 132.62K | — |
| Invesco Ltd | — | — | — | 34.69K | 36.45K | 36.84K | — |
| Geode Capital Management | — | 29.07K | 29.07K | 29.07K | 29.07K | 29.07K | — |
| XTX Topco Ltd | — | 48.87K | 44.15K | 59.29K | 34.59K | — | — |
| WINTON GROUP Ltd | — | 12.73K | 33.39K | 63.30K | 21.55K | — | — |
| MILLENNIUM MANAGEMENT LLC | — | — | — | — | 14.60K | — | — |
| Citadel Advisors | — | — | — | 30.58K | 11.69K | — | — |
| Tower Research Capital LLC (TRC) | — | — | 4.91K | 2.21K | 4.46K | 3.34K | 1 |
| GEODE CAPITAL MANAGEMENT, LLC | — | 29.07K | — | — | — | — | — |
| Morgan Stanley | — | 248 | 261 | 1.61K | 2.01K | 2.44K | 46 |
| BNP PARIBAS FINANCIAL MARKETS | — | — | — | — | — | 262 | — |
| JPMorgan Chase & Co | — | 134 | — | 457 | — | — | — |
| Bank of America Corp | — | — | — | — | — | 73 | — |
| Millennium Management | — | — | — | — | 14.60K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ZYBT?
As of 2026-Q3, 6 institutional funds reported holding ZYBT (ZHENGYE BIOTECHNOLOGY HLDG L) in SEC 13F filings, with a combined reported value of $64.40K.
How many shares of ZYBT do institutions own?
13F filers reported 50.38K shares of ZYBT, worth $64.40K in aggregate at the end of 2026-Q3.
Is institutional ownership of ZYBT rising or falling?
Share counts moved -41.0% versus the prior quarter — distribution.
Who are the top institutional holders of ZYBT?
The largest 13F holders are Pacer Advisors, Inc., Invesco Ltd, MILLENNIUM MANAGEMENT LLC, Millennium Management, Citadel Advisors; the top 25 are ranked at the top of this page.
Who are the major shareholders of ZHENGYE BIOTECHNOLOGY HLDG L?
The major shareholders of ZHENGYE BIOTECHNOLOGY HLDG L (ZYBT) by reported 13F value are Pacer Advisors, Inc., Invesco Ltd, MILLENNIUM MANAGEMENT LLC, Millennium Management, Citadel Advisors, among 20 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.